Sign Out
EVENITY is contraindicated in patients with: Hypocalcemia. Pre-existing hypocalcemia must be corrected prior to initiating therapy with EVENITY [see Hypocalcemia and Renal Impairment under Precautions and Adverse Reactions].
A history of systemic hypersensitivity to romosozumab or to any component of the product formulation. Reactions have included angioedema, erythema multiforme, and urticaria [see Hypersensitivity Reactions under Precautions and Adverse Reactions].
